160 related articles for article (PubMed ID: 12938012)
21. Comment: caspofungin acetate for treatment of invasive fungal infections.
Grau S; Mateu-De Antonio J
Ann Pharmacother; 2003 Dec; 37(12):1919. PubMed ID: 14632549
[No Abstract] [Full Text] [Related]
22. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
Kartsonis NA; Saah AJ; Joy Lipka C; Taylor AF; Sable CA
J Infect; 2005 Apr; 50(3):196-205. PubMed ID: 15780413
[TBL] [Abstract][Full Text] [Related]
23. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
[TBL] [Abstract][Full Text] [Related]
24. Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection.
Anttila VJ; Piilonen A; Valtonen M
Scand J Infect Dis; 2003; 35(11-12):893-4. PubMed ID: 14723374
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis.
Elanjikal Z; Sörensen J; Schmidt H; Dupuis W; Tintelnot K; Jautzke G; Klingebiel T; Lehrnbecher T
Pediatr Infect Dis J; 2003 Jul; 22(7):653-6. PubMed ID: 12867844
[TBL] [Abstract][Full Text] [Related]
26. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.
Bowman JC; Abruzzo GK; Anderson JW; Flattery AM; Gill CJ; Pikounis VB; Schmatz DM; Liberator PA; Douglas CM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3474-81. PubMed ID: 11709327
[TBL] [Abstract][Full Text] [Related]
27. Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis.
Maertens J
Int J Antimicrob Agents; 2006 Jun; 27(6):457-67. PubMed ID: 16701980
[TBL] [Abstract][Full Text] [Related]
28. New antifungal agents-treatment standards are beginning to grow old.
Maschmeyer G
J Antimicrob Chemother; 2002 Feb; 49(2):239-41. PubMed ID: 11815563
[No Abstract] [Full Text] [Related]
29. Efficacy of caspofungin against Aspergillus terreus.
Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Fallani S; Manso E; Pisa E; Giannini D; Novelli A; Cassetta MI; Mazzei T; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Dec; 49(12):5133-5. PubMed ID: 16304185
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study.
Maertens J; Glasmacher A; Selleslag D; Ngai A; Ryan D; Layton M; Taylor A; Sable C; Kartsonis N
Clin Infect Dis; 2005 Jul; 41(1):e9-14. PubMed ID: 15937754
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.
Kontoyiannis DP; Hachem R; Lewis RE; Rivero GA; Torres HA; Thornby J; Champlin R; Kantarjian H; Bodey GP; Raad II
Cancer; 2003 Jul; 98(2):292-9. PubMed ID: 12872348
[TBL] [Abstract][Full Text] [Related]
32. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
Sionov E; Mendlovic S; Segal E
J Antimicrob Chemother; 2005 Sep; 56(3):594-7. PubMed ID: 16006446
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.
Sionov E; Mendlovic S; Segal E
J Infect; 2006 Aug; 53(2):131-9. PubMed ID: 16360214
[TBL] [Abstract][Full Text] [Related]
34. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM
J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198
[TBL] [Abstract][Full Text] [Related]
35. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
36. Combination antifungal therapy for invasive aspergillosis.
Cesaro S; Visintin G
Clin Infect Dis; 2005 Apr; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
[No Abstract] [Full Text] [Related]
37. Oesophageal aspergillosis in a case of acute lymphoblastic leukaemia successfully treated with caspofungin alone due to liposomal amphotericin B induced severe hepatotoxicity.
Akyol Erikci A; Ozyurt M; Terekeci H; Ozturk A; Karabudak O; Oncu K
Mycoses; 2009 Jan; 52(1):84-6. PubMed ID: 18498301
[TBL] [Abstract][Full Text] [Related]
38. Aspergillus flavus sinusitis in ALL.
Keane C; Colreavy M; Lynch M; O'Gorman P
Am J Hematol; 2009 Feb; 84(2):123. PubMed ID: 19253415
[No Abstract] [Full Text] [Related]
39. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
[TBL] [Abstract][Full Text] [Related]
40. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.
Rubin MA; Carroll KC; Cahill BC
Clin Infect Dis; 2002 Apr; 34(8):1160-1. PubMed ID: 11915012
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
